MCL coexpression mm9:700
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr11:113427054..113427106,- | p1@Slc39a11 |
Mm9::chr11:5420973..5420992,+ | p1@Xbp1 |
Mm9::chr11:84683690..84683732,- | p4@Ggnbp2 |
Mm9::chr12:70285164..70285205,+ | p1@Mgat2 |
Mm9::chr15:88906488..88906535,+ | p1@Trabd |
Mm9::chr17:74738503..74738558,+ | p@chr17:74738503..74738558 + |
Mm9::chr5:31262609..31262693,- | p1@Preb |
Mm9::chr5:31262699..31262712,- | p2@Preb |
Mm9::chr6:108778627..108778715,+ | p1@Edem1 |
Mm9::chr8:72826660..72826703,+ | p1@Cope |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0005783 | endoplasmic reticulum | 0.0226217276537667 |
GO:0046462 | monoacylglycerol metabolic process | 0.0380066257364183 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 0.0380066257364183 |
GO:0003846 | 2-acylglycerol O-acyltransferase activity | 0.0380066257364183 |
GO:0019432 | triacylglycerol biosynthetic process | 0.0380066257364183 |
GO:0006651 | diacylglycerol biosynthetic process | 0.0380066257364183 |
GO:0030433 | ER-associated protein catabolic process | 0.0380066257364183 |
GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 0.0380066257364183 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 0.0380066257364183 |
GO:0043231 | intracellular membrane-bound organelle | 0.0380066257364183 |
GO:0043227 | membrane-bound organelle | 0.0380066257364183 |
GO:0015924 | mannosyl-oligosaccharide mannosidase activity | 0.0380066257364183 |
GO:0046460 | neutral lipid biosynthetic process | 0.0380066257364183 |
GO:0046463 | acylglycerol biosynthetic process | 0.0380066257364183 |
GO:0046504 | glycerol ether biosynthetic process | 0.0380066257364183 |
GO:0045017 | glycerolipid biosynthetic process | 0.0380066257364183 |
GO:0046339 | diacylglycerol metabolic process | 0.0380066257364183 |
GO:0050892 | intestinal absorption | 0.0380066257364183 |
GO:0030126 | COPI vesicle coat | 0.0380066257364183 |
GO:0030663 | COPI coated vesicle membrane | 0.0380066257364183 |
GO:0044444 | cytoplasmic part | 0.042213393607381 |
GO:0030137 | COPI-coated vesicle | 0.042213393607381 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 0.0429068815323417 |
GO:0022600 | digestive system process | 0.0429068815323417 |
GO:0016411 | acylglycerol O-acyltransferase activity | 0.0429068815323417 |
GO:0015923 | mannosidase activity | 0.0429068815323417 |
GO:0031410 | cytoplasmic vesicle | 0.0429068815323417 |
GO:0043229 | intracellular organelle | 0.0429068815323417 |
GO:0012505 | endomembrane system | 0.0429068815323417 |
GO:0043226 | organelle | 0.0429068815323417 |
GO:0031982 | vesicle | 0.0431141534842245 |
GO:0006641 | triacylglycerol metabolic process | 0.0481607130753447 |
GO:0006071 | glycerol metabolic process | 0.0481607130753447 |
GO:0019751 | polyol metabolic process | 0.0481607130753447 |
GO:0030176 | integral to endoplasmic reticulum membrane | 0.0481607130753447 |
GO:0006829 | zinc ion transport | 0.0497453160918431 |
GO:0005737 | cytoplasm | 0.0497453160918431 |
GO:0031227 | intrinsic to endoplasmic reticulum membrane | 0.0497453160918431 |
GO:0030120 | vesicle coat | 0.0497453160918431 |
GO:0006639 | acylglycerol metabolic process | 0.0497453160918431 |
GO:0046486 | glycerolipid metabolic process | 0.0497453160918431 |
GO:0006638 | neutral lipid metabolic process | 0.0497453160918431 |
GO:0030662 | coated vesicle membrane | 0.0497453160918431 |
GO:0006662 | glycerol ether metabolic process | 0.0497453160918431 |
Relative expression of the co-expression cluster over median <br>Analyst:
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |